BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18484356)

  • 1. Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers.
    Mesia-Vela S; Yeh CC; Austin JH; Dounel M; Powell CA; Reeves A; Santella RM; Stevenson L; Yankelevitz D; Barr RG
    Biomarkers; 2008 Jun; 13(4):422-34. PubMed ID: 18484356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
    Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
    Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative analysis of emphysema and air trapping at inspiratory and expiratory phase multi-slice spiral CT scan in smokers: correlation with pulmonary function test].
    Zhang D; Guan Y; Fan L; Xia Y; Liu SY
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1467-1473. PubMed ID: 29804412
    [No Abstract]   [Full Text] [Related]  

  • 4. Kurtosis and skewness of density histograms on inspiratory and expiratory CT scans in smokers.
    Yamashiro T; Matsuoka S; Estépar RS; Bartholmai BJ; Diaz A; Ross JC; Murayama S; Silverman EK; Hatabu H; Washko GR
    COPD; 2011 Feb; 8(1):13-20. PubMed ID: 21299474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts.
    Tho NV; Ryujin Y; Ogawa E; Trang le TH; Kanda R; Goto K; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Respirology; 2015 May; 20(4):594-601. PubMed ID: 25788016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of C-reactive protein with disease severity in CT diagnosed emphysema.
    Omori H; Tsuji M; Sata K; Iyonaga C; Narimatsu A; Mihara S; Marubayashi T; Tomiguchi S; Nomori H; Kohrogi H; Katoh T
    Respirology; 2009 May; 14(4):551-8. PubMed ID: 19386068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
    Rahman I; Swarska E; Henry M; Stolk J; MacNee W
    Thorax; 2000 Mar; 55(3):189-93. PubMed ID: 10679536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
    Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA;
    Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
    Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
    Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
    Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD.
    D'Anna SE; Asnaghi R; Caramori G; Appendini L; Rizzo M; Cavallaro C; Marino G; Cappello F; Balbi B; Di Stefano A
    Respiration; 2012; 83(5):383-90. PubMed ID: 21832824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.
    Yuan R; Hogg JC; Paré PD; Sin DD; Wong JC; Nakano Y; McWilliams AM; Lam S; Coxson HO
    Thorax; 2009 Nov; 64(11):944-9. PubMed ID: 19734130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography-quantified emphysema distribution is associated with lung function decline.
    Mohamed Hoesein FA; van Rikxoort E; van Ginneken B; de Jong PA; Prokop M; Lammers JW; Zanen P
    Eur Respir J; 2012 Oct; 40(4):844-50. PubMed ID: 22323577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of emphysema in heavy smokers: impact on pulmonary function.
    Gietema HA; Zanen P; Schilham A; van Ginneken B; van Klaveren RJ; Prokop M; Lammers JW
    Respir Med; 2010 Jan; 104(1):76-82. PubMed ID: 19734030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
    Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung dysfunction of chronic smokers with no signs of COPD.
    Nagelmann A; Tonnov Ä; Laks T; Sepper R; Prikk K
    COPD; 2011 Jun; 8(3):189-95. PubMed ID: 21513442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between airflow obstruction, emphysema extent, and small airways function in COPD.
    Timmins SC; Diba C; Farrow CE; Schoeffel RE; Berend N; Salome CM; King GG
    Chest; 2012 Aug; 142(2):312-319. PubMed ID: 22345381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.